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598a Wednesday, February 11, 2015phosphorylation to decrease myofilament calcium sensitivity and accelerate
myofilament relaxation. Furthermore, Tyr-26 phosphorylation can buffer the
desensitization of Ser-23/24 phosphorylation while further accelerating thin
filament deactivation upon their integration. Therefore, the functional integ-
ration of TnI phosphorylation may be a common mechanism to modulate
Ser-23/24 phosphorylation function.
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Slow ventricular cardiac myosin (bmys) has three distinct unitary step-sizes,
nominally 3, 5, and 8 nm, that move actin with varying step-frequencies. Ventric-
ular cardiac myosin essential light chain (vELC) has a 43 residue N-terminal
extension that binds actin. The basis for the three unitary steps in cardiac myosin
was proposed to involve actin bindingof the vELCextensionwherein the predom-
inant 5 nm step does not engage the actin/vELC linkage, the slightly less likely 8
nmstep engages actin/vELC linkage facilitating an extra ~19degrees of lever-arm
rotation, and theminor 3 nm step is the unlikely conversion of the 5 nm step to the
full actin/vELC bound 8 nm step. The hypothesis was tested using several cardiac
myosin constructs including a 17 residue N-terminal truncated vELC in porcine
mys (D17) and a 43 residueN-terminal truncated humanvELCexpressed in trans-
genic mouse heart (D43). Mouse myosin heavy chain is the fast isoform (amys).
Cardiacmyosin step-size and relative step-frequencyweremeasured using a high
throughputQdot super-resolution in vitromotility assay.D17 showeda significant
increase to the 5 nm step-frequency and coincident reduction to the 3 and 8 nm
step-frequencies implying a reduction in probability for forming vELC/actin link-
age. Nontransgenic (NTg) and human vELCexpressedamys in transgenicmouse
heart had three unitary step-sizes like those in bmys although step-frequencies in
NTg were redistributed to favor the 8 nm step.D43 showed a significant increase
to the 5 nm step-frequency and a significant reduction to the combined 3 and 8 nm
step-frequency again indicating lower overall probability for forming vELC/actin
linkage.Data strongly supports the hypothesis that the vELCextension is the basis
for three step-sizes in cardiac myosin. Supported by NIH grants R01AR049277,
R01HL095572, and R01HL108343.
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Hypertrophic cardiomyopathy (HCM) is an inherited disease of the heart mus-
cle that affects approximately 1 in 500 individuals. The condition is character-
ized by enlarged cardiac myocytes, thickened ventricular walls, non-compliant
muscle structure, changes in blood pressure, electrical arrhythmias, and short-
ness of breath. The Arg-to-Gln switch at amino acid 403 of beta-myosin heavy
chain (MHC-R403Q) is the most prevalent mutation associated with familial
HCM. Human induced pluripotent stem (iPS) cell-derived cardiomyocytes
can be generated in highly pure and large quantities from both control and
affected individuals to provide a path forward toward better mechanistic under-
standing of complex heart diseases.
Endothelin-1 (ET-1)-induced cardiac hypertrophy in human iPS cell-derived car-
diomyocytes exhibits several classic hallmarks of cardiac hypertrophy including
up-regulation of the fetal gene expression program, cytoskeletal rearrangements,
and an increase in cardiomyocyte cell size (Carlson et al., 2013). Similar to the
induced hypertrophic state, here we describe novel information regarding innate
cardiac hypertrophy associated with MHC-R403Q. iPS cell-derived cardiomyo-
cytes were generated from an MHC-R403Q-positive individual exhibiting the
HCM phenotype. MHC-R403Q cardiomyocytes were generated at high purity
(>95% TNNT-positive), exhibited the expected cardiac morphology, and
showed autonomous contractile activity similar to the control cardiomyocytes
(non-MHC-R403Q). Transcript profiling demonstrated that basal gene expres-
sion of MHC-R403Q cardiomyocytes was similar to control cardiomyocytes
that had been induced with ET-1 into a hypertrophic state. Similarly, basal
BNP levels inMHC-R403Q cardiomyocytes were higher than those of uninduced
control cardiomyocytes. Interestingly, when treated with ET-1, cardiomyocytes
from both backgrounds exhibited increases in BNP expression to similar levels.
These data suggest thatMHC-R403Q cardiomyocytes may have an innate predis-
position toward familial hypertrophic cardiomyopathy and underscore the advan-
tages of modeling cardiovascular disease through the use of iPSC technology.Cytoskeletal-based Intracellular Transport
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Intracellular transport is largely driven by processive microtubule- and actin-
based molecular motors. Non-processive motors have also been localized
to trafficking cargos, but their roles are not well understood. Myosin-Ic
(Myo1c), a non-processive actin motor, functions in a variety of exocytic events,
although the underlying mechanisms are not yet clear. To investigate the inter-
play between myosin-I and the canonical long distance transport motor kinesin-
1, we attached both motor types to lipid membrane-coated bead (MBC) cargo,
using an attachment strategy that allows motors to actively reorganize within the
membrane in response to the local cytoskeletal environment. We compared the
motility of kinesin-1-driven cargos in the absence and presence of Myo1c at en-
gineered actin/microtubule intersections. We found that Myo1c significantly in-
creases the frequency of kinesin-1-driven microtubule-based runs that begin at
actin/microtubule intersections. Myo1c also regulates the termination of proces-
sive runs. Beads with both motors-bound have a significantly higher probability
of pausing at actin/microtubule intersections, remaining tethered for an average
of 20 s, with some pauses lasting longer than 200 s. The actin-binding protein
non-muscle tropomyosin (Tm) provides spatially-specific regulation of inter-
actions between myosin motors and actin filaments in vivo; in vitro, we found
that Tm2 abrogates Myo1c-driven actin gliding. In the crossed-filament assay,
Tm2-actin abolishes Myo1c-specific effects on both run initiation and run termi-
nation. Together these observations suggest Myo1c is important for the selective
initiation and termination of kinesin-driven runs along microtubules at specific
actin filament populations within the cell.
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Mammalian pigmentation is driven by the intercellular transfer of pigment-
containing melanosomes from the tips of melanocyte dendrites to surrounding
keratinocytes. Using time lapse imaging of primarymousemelanocyte/keratino-
cyte co-cultures prepared from transgenic mice (‘‘Holly’’ mice) in which the
plasma membranes of melanocytes and keratinocytes are red and green, respec-
tively, we recently defined an intercellular melanosome transfer pathway that in-
volves the shedding by the melanocyte of melanosome-rich packages, which are
subsequently phagocytosed by the keratinocyte (Wu et al.; PNAS; 2012). Shed-
ding, which occurs primarily at the tips of the melanocyte’s dendrites, involves
adhesion of the dendrite to the keratinocyte, thinning of the dendrite behind the
forming package, and an apparent self-abscission event that deposits a plasma
membrane-enclosed package ofmelanosomes on the surface of the keratinocyte.
After a variable period of time, the keratinocyte then internalizes this package by
phagocytosis, completely the intercellular transfer of pigment. To determine if
this shedding mechanism also drives melanosome transfer in vivo, we have per-
formed time lapse imaging of ear skin on anesthetized Holly mice. The bound-
aries of red melanocytes and green keratinocytes are clearly visible in the skin,
and the distribution and dynamics of black melanosomes inside both cell types
can be followed in three dimensions. Numerous events that occur along the sides
and tips of melanocyte dendrites, and that appear to be abortive shedding events,
have been seen. To augment transfer, which is probably very infrequent in skin,
we have treated the animal’s ear skin with forskolin-containing cream to
augment pigment synthesis and transfer. Recent imaging yielded several transfer
events that involved shedding of a melanosome-rich package by the melanocyte
and subsequent phagocytosis of the package by the keratinocyte, arguing that the
mechanism we defined previously in co culture also occurs in vivo.
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Tauproteins areexpressedabundantly inhumanneurons, and areknown to regulate
the dynamics and structures of cytoskeletal microtubule filaments. Tau mutations
andmisregulation cancause severe neurodegenerative dementiadiseases including
